4//SEC Filing
Yates Clayton Clopton 4
Accession 0001903596-25-000319
CIK 0001792941other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 7:32 PM ET
Size
5.4 KB
Accession
0001903596-25-000319
Insider Transaction Report
Form 4
Genvor IncGNVR
Yates Clayton Clopton
Director10% Owner
Transactions
- Award
Common Stock
2025-05-08$0.25/sh+400,000$100,000→ 400,000 total(indirect: By LLC)
Footnotes (2)
- [F1]Conversion of $100,000 in accrued payables due to Dr. Yates at $0.25/share. The issuance of the 400K shares to Clayton in consideration of his conversion of $100K in accrued payables, pursuant to Dr. Yates's restructured compensation package, which permits Dr. Yates to convert amounts due to him into common stock.
- [F2]Dr. Yates is a manager of, and may therefore be deemed to be the beneficial owner of shares held in the name of, ACT Holdings, LLC.
Documents
Issuer
Genvor Inc
CIK 0001792941
Entity typeother
Related Parties
1- filerCIK 0002000242
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 7:32 PM ET
- Size
- 5.4 KB